<DOC>
	<DOCNO>NCT02044224</DOCNO>
	<brief_summary>The purpose study evaluate effect dexmedetomidine anaesthesia IRE procedure solid tumour</brief_summary>
	<brief_title>Effects Dexmedetomidine During IRE Procedures Solid Tumours</brief_title>
	<detailed_description>Pulsed electric current use produce irreversible electroporation ( IRE ) cell membrane result cell death . This process show ablate tumor animal human study . A pulsate direct current 20 50 A 500 3000 V deliver metastatic primary tumor liver , kidney , lung via needle electrode insert computed tomography ( CT ) ultrasound guidance . Patients usually require general anesthesia muscle relaxant . Currently , circa 30 procedure do institution good excellent result . However , several patient severe pain postoperatively . Dexmedetomidine α2-adrenoreceptor agonist sedative , analgesic anxiolytic effect , selective α2-adrenergic effect clonidine . We evaluate perioperative dexmedetomidine 0.4 µg/kg/hr infusion effect hemodynamics , anesthetic consumption , recovery profile anesthesia IRE solid organ tumour .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1. liver or/and pancreas cancer IRE procedure plan 2. sign informed consent form 1. patient refusal 2. pregnancy 3. know allergy dexmedetomidine anaesthesia drug 4. atrioventricular block grade II III significant cardiac conduction disturbance 5. stroke 6. low blood pressure respond treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>